Keywords: cytel, regains, rights, cardiovascular, candidate, cy1748, pharmacia

Cytel Regains Rights To Cardiovascular Candidate CY1748

Article | 13 January 1997

Print This

Pharmacia & Upjohn has decided not to proceed with the development ofCY1748, Cytel Corp's drug candidate for treating deep vein thrombosis. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in